Cyclacel Pharmaceuticals, Inc. (CYCC) At $1.78 Forms Bottom; 2 Analysts Are Bullish Crocs, Inc. (CROX) Last Week

Among 10 analysts covering Crocs (NASDAQ:CROX), 2 have Buy rating, 0 Sell and 8 Hold. Therefore 20% are positive. Crocs had 25 analyst reports since August 11, 2015 according to SRatingsIntel. Susquehanna initiated it with “Neutral” rating and $9.50 target in Friday, August 12 report. Robert W. Baird maintained the shares of CROX in report on Monday, January 8 with “Hold” rating. Stifel Nicolaus downgraded Crocs, Inc. (NASDAQ:CROX) on Wednesday, April 27 to “Hold” rating. The firm has “Buy” rating given on Tuesday, August 11 by Piper Jaffray. The firm earned “Buy” rating on Monday, November 9 by Monness Crespi & Hardt. Monness Crespi & Hardt downgraded the stock to “Neutral” rating in Thursday, November 10 report. Piper Jaffray downgraded the stock to “Neutral” rating in Thursday, October 1 report. The firm has “Buy” rating by Sterne Agee CRT given on Friday, August 14. Piper Jaffray maintained it with “Hold” rating and $900 target in Wednesday, August 9 report. B. Riley & Co maintained the stock with “Neutral” rating in Thursday, October 1 report. See Crocs, Inc. (NASDAQ:CROX) latest ratings:

08/01/2018 Broker: Robert W. Baird Rating: Hold New Target: $14.0 Maintain
08/01/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $16.0 Maintain
15/12/2017 Broker: Stifel Nicolaus Old Rating: Hold New Rating: Buy Upgrade
20/11/2017 Broker: C.L. King Rating: Hold Downgrade
07/11/2017 Broker: Pivotal Research Rating: Hold New Target: $10.0
20/10/2017 Broker: Robert W. Baird Rating: Hold New Target: $9.0 Maintain
05/10/2017 Broker: Pivotal Research Rating: Hold New Target: $9.5 Initiates Coverage On
15/09/2017 Broker: Robert W. Baird Rating: Hold New Target: $9.0 Maintain
10/08/2017 Broker: Susquehanna Rating: Hold Maintain
09/08/2017 Broker: Piper Jaffray Rating: Hold New Target: $9.0000 Maintain

Cyclacel Pharmaceuticals, Inc. (CYCC) formed multiple bottom with $1.67 target or 6.00% below today’s $1.78 share price. Cyclacel Pharmaceuticals, Inc. (CYCC) has $21.19M valuation. The stock increased 1.71% or $0.03 during the last trading session, reaching $1.78. About 264,459 shares traded. Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) has risen 10.62% since January 27, 2017 and is uptrending. It has underperformed by 6.08% the S&P500.

Investors sentiment decreased to 0 in Q3 2017. Its down Infinity, from Infinity in 2017Q2. It dropped, as 0 investors sold Cyclacel Pharmaceuticals, Inc. shares while 0 reduced holdings. 0 funds opened positions while 0 raised stakes. 13,295 shares or 0.00% without change from 13,295 shares in 2017Q2 were reported. Baker Bros Advsr Ltd Partnership holds 0% or 13,253 shares. Tower Rech Cap Ltd Liability Com (Trc) accumulated 42 shares or 0% of the stock.

Investors sentiment decreased to 1.06 in 2017 Q3. Its down 0.35, from 1.41 in 2017Q2. It worsened, as 17 investors sold Crocs, Inc. shares while 46 reduced holdings. 27 funds opened positions while 40 raised stakes. 60.66 million shares or 1.19% less from 61.39 million shares in 2017Q2 were reported. Barrow Hanley Mewhinney & Strauss Ltd holds 0% or 208,456 shares in its portfolio. Savings Bank Of Mellon Corp reported 908,200 shares. Hutchin Hill Ltd Partnership stated it has 0.02% in Crocs, Inc. (NASDAQ:CROX). The Arizona-based Arizona State Retirement Sys has invested 0% in Crocs, Inc. (NASDAQ:CROX). Ancora Advsrs Lc, Us-based fund reported 73,770 shares. 148,974 were reported by Rhumbline Advisers. Geode Capital Mgmt Limited Liability holds 675,841 shares. State Of Alaska Department Of Revenue has invested 0.01% in Crocs, Inc. (NASDAQ:CROX). Goldman Sachs Grp reported 376,378 shares. California State Teachers Retirement invested 0% in Crocs, Inc. (NASDAQ:CROX). Driehaus Cap Mgmt Ltd Liability Company invested in 0.32% or 842,772 shares. Systematic Fincl Mngmt Lp has 169,335 shares. Natixis has invested 0% in Crocs, Inc. (NASDAQ:CROX). 129,134 were reported by Pinebridge Investments L P. Guggenheim Cap Ltd Limited Liability Company invested in 99,558 shares or 0% of the stock.